Literature DB >> 6178757

Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.

S L Gonias, M Einarsson, S V Pizzo.   

Abstract

The catabolic pathways of streptokinase, plasmin, and activator complex prepared with human plasminogen were studied in mice. (125)I-streptokinase clearance occurred in the liver and was 50% complete in 15 min. Incubation with mouse plasma had no effect on the streptokinase clearance rate. Complexes of plasmin and alpha(2)-plasmin inhibitor were eliminated from the plasma by a specific and saturable pathway. Competition experiments demonstrated that this pathway is responsible for the clearance of injected plasmin. Streptokinase-plasminogen activator complex formed with either (125)I-plasminogen or (125)I-streptokinase cleared in the liver at a significantly faster rate than either of the uncomplexed proteins (50% clearance in <3 min). Streptokinase incubated with human plasma also demonstrated this accelerated clearance. p-Nitrophenyl-p'-guanidinobenzoate-HCl or pancreatic trypsin inhibitor-treated complex cleared slowly compared with untreated complex independent of which protein was radiolabeled. Significant competition for clearance was demonstrated between alpha(2)-macroglobulin-trypsin and activator complex only when the plasmin(ogen) was the radiolabeled moiety. Large molar excesses of alpha(2)-plasmin inhibitor-plasmin failed to retard the clearance of activator complex. Hepatic binding of streptokinase-plasmin, in liver perfusion experiments, was dependent upon prior incubation with plasma (8-10% uptake compared to a background of approximately 2.5%). Substitution of human alpha(2)-macroglobulin for plasma also resulted in binding when the incubation was performed for 10 min at 37 degrees C (7.5%). Electrophoresis experiments confirmed the transfer of 0.8 mol plasmin/mol alpha(2)-macroglobulin when activator complex was incubated at 37 degrees C with alpha(2)-macroglobulin for 40 min. Streptokinase transfer from activator complex to alpha(2)-macroglobulin was negligible. The in vivo clearance of activator complex is proposed to involve active attack of the complex on the alpha(2)-macroglobulin "bait region," resulting in facilitated plasmin transfer. Dissociated streptokinase is rapidly bound and cleared by sites in the liver.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178757      PMCID: PMC371250          DOI: 10.1172/jci110631

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy.

Authors:  A P FLETCHER; N ALKJAERSIG; F E SMYRNIOTIS; S SHERRY
Journal:  Trans Assoc Am Physicians       Date:  1958

2.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

3.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

4.  Radiolabeled streptokinase and urokinase and their comparative biodistribution.

Authors:  P Som; B A Rhodes; W R Bell
Journal:  Thromb Res       Date:  1975-03       Impact factor: 3.944

5.  Protein iodination with solid state lactoperoxidase.

Authors:  G S David; R A Reisfeld
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

6.  Mechanism of proteinase complex formation with alpha 2-macroglobulin. Three modes of trypsin binding.

Authors:  L Sottrup-Jensen; T E Petersen; S Magnusson
Journal:  FEBS Lett       Date:  1981-06-01       Impact factor: 4.124

7.  Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.

Authors:  P Lollar; W G Owen
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

8.  Studies on plasminogen. 8. Species specificity of streptokinase.

Authors:  R J Wulf; E T Mertz
Journal:  Can J Biochem       Date:  1969-10

9.  Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin.

Authors:  M J Imber; S V Pizzo
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

10.  Activation of human plasminogen by equimolar levels of streptokinase.

Authors:  A P Bajaj; F J Castellino
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

View more
  15 in total

1.  Model of alpha 2-macroglobulin structure and function.

Authors:  S R Feldman; S L Gonias; S V Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

2.  Purification and characterization of human alpha 2-macroglobulin conformational variants by non-ideal high performance size-exclusion chromatography.

Authors:  S L Gonias; P A Roche; S V Pizzo
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

3.  Kinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism.

Authors:  P K Anonick; W H Vetter; S L Gonias
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

4.  Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.

Authors:  S L Gonias; N L Figler
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

5.  Reagents for reversible coupling of proteins to the active centres of trypsin-like serine proteinases.

Authors:  S B Kalindjian; R A Smith
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

6.  The protective effect of acylation on the stability of anisoylated plasminogen streptokinase activator complex in human plasma.

Authors:  R Fears; H Ferres; R Standring
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 7.  Pathogen activators of plasminogen.

Authors:  I M Verhamme; P R Panizzi; P E Bock
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

8.  The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.

Authors:  R Cassels; R Fears; R A Smith
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

9.  Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.

Authors:  D J Webb; K P Crookston; N L Figler; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors.

Authors:  H E Fuchs; S V Pizzo
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.